tranexamic acid has been researched along with Carcinoma in Situ in 1 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
Carcinoma in Situ: A lesion with cytological characteristics associated with invasive carcinoma but the tumor cells are confined to the epithelium of origin, without invasion of the basement membrane.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grundsell, H | 1 |
| Larsson, G | 1 |
| Bekassy, Z | 1 |
1 trial available for tranexamic acid and Carcinoma in Situ
| Article | Year |
|---|---|
Use of an antifibrinolytic agent (tranexamic acid) and lateral sutures with laser conization of the cervix.
Topics: Carcinoma in Situ; Cervix Uteri; Clinical Trials as Topic; Curettage; Cyclohexanecarboxylic Acids; F | 1984 |